REG - Inspiration Health - Grant of Options

Inspiration HealthcareAnnouncement

03/04/2023 18:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230403:nRSC2247Va&default-theme=true

RNS Number : 2247V  Inspiration Healthcare Group PLC  03 April 2023

03 April 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Grant of Options

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company, announces that it has granted a total of 459,512 nil cost options
over ordinary shares of 10 pence each in the capital of the Company
("Options") under the Inspiration Healthcare Group Long Term Incentive Plan
(the "LTIP"), including a total of 330,625 Options to four Persons Discharging
Managerial Responsibilities ("PDMRs") as detailed below.

The Options are exercisable at nil cost and are subject to operational
performance criteria measured over a three year period ending on 31 January
2025.

 

For further information:

 Inspiration Healthcare Group plc                                              Tel: +44  (0)330 175 0000

 Neil Campbell, Chief Executive Officer
 Cenkos Securities plc (Nominated Adviser & Broker)                            Tel: +44 (0)207 397 8900
 Stephen Keys, Katy Birkin, Dan Hodkinson

 Walbrook PR Ltd (Media and Investor Relations)  Tel: +44 (0)20 7933 8780
 Anna Dunphy/Stephanie Cuthbert

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 1     Details of the person discharging managerial responsibilities / person closely
       associated
 a)    Name                                                         1.  Neil Campbell

                                                                    2.  Brook Nolson

                                                                    3.  Martin Pearcy

                                                                    4.  Peter Reynolds
 2     Reason for the notification
 a)    Position/status                                              1.  PDMR

                                                                    2.  PDMR

                                                                    3.  PDMR

                                                                    4.  PDMR
 b)    Initial notification /Amendment                              Initial
 3     Details of the issuer, emission allowance market participant, auction
       platform, auctioneer or auction monitor
 a)    Name                                                         Inspiration Healthcare Group plc

 b)    LEI                                                          213800GKFT3ENAPMDL15

 4     Details of the transaction(s): section to be repeated for (i) each type of

     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the financial instrument, type of instrument  Options over Ordinary Shares of 10p each in the capital of the Company

       Identification code                                          ISIN: GB00BXDZL105
 b)    Nature of the transaction                                    Grant of Options under the Long Term Incentive Plan
 c)    Price(s) and volume(s)

Price(s)  Volume(s)
                                                                    1. Nil    1. 115,000

                                                                    2. Nil    2. 92,000

                                                                    3. Nil    3. 77,625

                                                                    4. Nil    4. 46,000

 

 d)    Aggregated information

       - Aggregated volume

N/A - single transaction
       - Price

 e)    Date of the transaction                                      31 March 2023
 f)    Place of the transaction                                     Outside of a trading venue

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

 

N/A - single transaction

 

e)

Date of the transaction

31 March 2023

f)

Place of the transaction

Outside of a trading venue

 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology
for use in neonatal intensive care & operating theatres. The Company
provides high quality innovative products to patients around the world which
help to improve patient outcomes and it actively invests in innovative product
opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days
of life to help premature and sick babies; helping resuscitation and
stabilisation in the first moments of life through to preventing brain damage
and both invasive and non-invasive respiratory support in terms of capital
equipment and disposable medical devices. Additionally, the Company has its
own range of products for maintaining normothermia pre, during and
post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer,
manufacturer and supplier of single use respiratory products and sterile
medical consumables and S.L.E., a leading designer, manufacturer and global
provider of neonatal ventilation products.  The Group generates approximately
58% of its revenues from export markets and more than half of its revenues
come from its own-branded products.

With product availability actively promoted to over 80 countries through a
distribution network, Inspiration Healthcare's success has been built on
continuous innovation, excellent customer service and an inherent commitment
to improving patient outcomes, working in close collaboration with key opinion
leaders across the globe.

In the UK and Ireland, the Group has direct sales teams selling Group Branded
and complementary products from third parties, with an additional range of
home healthcare products.  This is supported by Technical Support for planned
preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and
operations with manufacturing based in Croydon (south London) and Hailsham
(East Sussex).  The Group's Head Office is located in Crawley, a short
distance from London's Gatwick Airport.

Further information on Inspiration Healthcare can be found
at www.inspirationhealthcaregroup.com
(https://urldefense.proofpoint.com/v2/url?u=http-3A__www.inspirationhealthcaregroup.com&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=qE1yMNvX8OUmO7FV4SLAuFx81K4O8nrPcCbRUEpXKXA&m=AsjyE6dIARHBI2srhLsFJ1FNF6k58JhlTqEi2mPCslc&s=6wj1SWY-lTlBNmgGCdsoxZp8j2t1ASo3qHBlM01KC4Q&e=)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHQXLFBXZLEBBB